Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Recently published
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Recently published
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI Insight
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Expression of Concern Free access | 10.1172/jci.insight.126616

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes

Huan Yang, Haichao Wang, Yaakov A. Levine, Manoj K. Gunasekaran, Yongjun Wang, Meghan Addorisio, Shu Zhu, Wei Li, Jianhua Li, Dominique P.V. de Kleijn, Peder S. Olofsson, H. Shaw Warren, Mingzhu He, Yousef Al-Abed, Jesse Roth, Daniel J. Antoine, Sangeeta S. Chavan, Ulf Andersson, and Kevin J. Tracey

Find articles by Yang, H. in: JCI | PubMed | Google Scholar

Find articles by Wang, H. in: JCI | PubMed | Google Scholar

Find articles by Levine, Y. in: JCI | PubMed | Google Scholar

Find articles by Gunasekaran, M. in: JCI | PubMed | Google Scholar

Find articles by Wang, Y. in: JCI | PubMed | Google Scholar

Find articles by Addorisio, M. in: JCI | PubMed | Google Scholar

Find articles by Zhu, S. in: JCI | PubMed | Google Scholar

Find articles by Li, W. in: JCI | PubMed | Google Scholar

Find articles by Li, J. in: JCI | PubMed | Google Scholar

Find articles by de Kleijn, D. in: JCI | PubMed | Google Scholar

Find articles by Olofsson, P. in: JCI | PubMed | Google Scholar

Find articles by Warren, H. in: JCI | PubMed | Google Scholar

Find articles by He, M. in: JCI | PubMed | Google Scholar

Find articles by Al-Abed, Y. in: JCI | PubMed | Google Scholar

Find articles by Roth, J. in: JCI | PubMed | Google Scholar

Find articles by Antoine, D. in: JCI | PubMed | Google Scholar

Find articles by Chavan, S. in: JCI | PubMed | Google Scholar

Find articles by Andersson, U. in: JCI | PubMed | Google Scholar

Find articles by Tracey, K. in: JCI | PubMed | Google Scholar

Published December 20, 2018 - More info

Published in Volume 3, Issue 24 on December 20, 2018
JCI Insight. 2018;3(24):e126616. https://doi.org/10.1172/jci.insight.126616.
Copyright © 2018, American Society for Clinical Investigation
Published December 20, 2018 - Version history
View PDF

Related article:

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes
Huan Yang, … , Ulf Andersson, Kevin J. Tracey
Huan Yang, … , Ulf Andersson, Kevin J. Tracey
Haptoglobin binds and sequesters the damage-associated molecular pattern (DAMP) inflammatory mediator HMGB1 through a CD163-dependent mechanism.
Research Article Hepatology Immunology

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes

  • Text
  • PDF
Abstract

Secreted by activated cells or passively released by damaged cells, extracellular HMGB1 is a prototypical damage-associated molecular pattern (DAMP) inflammatory mediator. During the course of developing extracorporeal approaches to treating injury and infection, we inadvertently discovered that haptoglobin, the acute phase protein that binds extracellular hemoglobin and targets cellular uptake through CD163, also binds HMGB1. Haptoglobin-HMGB1 complexes elicit the production of antiinflammatory enzymes (heme oxygenase-1) and cytokines (e.g., IL-10) in WT but not in CD163-deficient macrophages. Genetic disruption of haptoglobin or CD163 expression significantly enhances mortality rates in standardized models of intra-abdominal sepsis in mice. Administration of haptoglobin to WT and to haptoglobin gene-deficient animals confers significant protection. These findings reveal a mechanism for haptoglobin modulation of the inflammatory action of HMGB1, with significant implications for developing experimental strategies targeting HMGB1-dependent inflammatory diseases.

Authors

Huan Yang, Haichao Wang, Yaakov A. Levine, Manoj K. Gunasekaran, Yongjun Wang, Meghan Addorisio, Shu Zhu, Wei Li, Jianhua Li, Dominique P.V. de Kleijn, Peder S. Olofsson, H. Shaw Warren, Mingzhu He, Yousef Al-Abed, Jesse Roth, Daniel J. Antoine, Sangeeta S. Chavan, Ulf Andersson, Kevin J. Tracey

×

Original citation: JCI Insight. 2016;1(7):e85375. https://doi.org/10.1172/jci.insight.85375

Citation for this expression of concern: JCI Insight. 2018;3(24):e126616. https://doi.org/10.1172/jci.insight.126616

An investigative committee at the University of Liverpool recently identified concerns regarding the integrity of the NMR data contributed by Daniel J. Antoine for Figure 1, E and F, of this paper. The Editorial Board is issuing this Expression of Concern to alert readers to this problem. No issues have been raised in regard to any of the other data in this manuscript.

Footnotes

See the related article at Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.

Version history
  • Version 1 (December 20, 2018): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI Insight

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement
Follow JCI Insight:
Copyright © 2021 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts